{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T21:14:58Z","timestamp":1788556498002,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000276","name":"United Kingdom Department of Health & Social Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Advances"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.omta.2026.201733","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T17:15:30Z","timestamp":1775495730000},"page":"201733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Using the nose as a factory to secrete proteins into the lungs or circulation"],"prefix":"10.1016","volume":"34","author":[{"given":"Anthony","family":"Sinadinos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia Ivette","family":"Juarez-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuixiang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Castells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana A.","family":"Viegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah R.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Hyde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8254-4540","authenticated-orcid":false,"given":"Uta","family":"Griesenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric W.F.W.","family":"Alton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omta.2026.201733_bib1","doi-asserted-by":"crossref","first-page":"S352","DOI":"10.1513\/AnnalsATS.201506-344KV","article-title":"Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease","volume":"13","author":"Chiuchiolo","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.omta.2026.201733_bib2","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1056\/NEJMoa2211075","article-title":"Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A","volume":"388","author":"Mahlangu","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omta.2026.201733_bib3","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1056\/NEJMoa2211644","article-title":"Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B","volume":"388","author":"Pipe","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omta.2026.201733_bib4","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1172\/JCI0215780","article-title":"Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins","volume":"110","author":"Auricchio","year":"2002","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omta.2026.201733_bib5","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.4161\/mabs.34454","article-title":"VEGF neutralizing aerosol therapy in primary pulmonary adenocarcinoma with K-ras activating-mutations","volume":"6","author":"Herv\u00e9","year":"2014","journal-title":"mAbs"},{"key":"10.1016\/j.omta.2026.201733_bib6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41434-018-0025-8","article-title":"The murine lung as a factory to produce secreted intrapulmonary and circulatory proteins","volume":"25","author":"Paul-Smith","year":"2018","journal-title":"Gene Ther."},{"key":"10.1016\/j.omta.2026.201733_bib7","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s40290-023-00495-7","article-title":"The Pharmacokinetics of Drugs Delivered to the Upper Nasal Space","volume":"37","author":"Shrewsbury","year":"2023","journal-title":"Pharm. Med. (Lond.)"},{"key":"10.1016\/j.omta.2026.201733_bib8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1006\/mthe.2002.0524","article-title":"The nasal epithelium as a factory for systemic protein delivery","volume":"5","author":"Griesenbach","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201733_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.591897","article-title":"As Plain as the Nose on Your Face: The Case for A Nasal (Mucosal) Route of Vaccine Administration for Covid-19 Disease Prevention","volume":"11","author":"Travis","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omta.2026.201733_bib10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/thoraxjnl-2016-208406","article-title":"Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis","volume":"72","author":"Alton","year":"2017","journal-title":"Thorax"},{"key":"10.1016\/j.omta.2026.201733_bib11","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1164\/rccm.201206-1056OC","article-title":"Assessment of F\/HN-pseudotyped lentivirus as a clinically relevant vector for lung gene therapy","volume":"186","author":"Griesenbach","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.omta.2026.201733_bib12","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1164\/rccm.202402-0389CI","article-title":"Lentiviral Gene Therapy for Cystic Fibrosis: A Promising Approach and First-in-Human Trial","volume":"210","author":"Davies","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.omta.2026.201733_bib13","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/mt.2010.13","article-title":"Toward gene therapy for cystic fibrosis using a lentivirus pseudotyped with Sendai virus envelopes","volume":"18","author":"Mitomo","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201733_bib14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.omtm.2022.07.002","article-title":"Sendai F\/HN pseudotyped lentiviral vector transduces human ciliated and non-ciliated airway cells using alpha 2,3 sialylated receptors","volume":"26","author":"Munday","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201733_bib15","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/bjc.1989.28","article-title":"Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) given as daily short infusions--a phase I dose-toxicity study","volume":"59","author":"Steward","year":"1989","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.omta.2026.201733_bib16","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.omtm.2022.04.002","article-title":"Correction of a chronic pulmonary disease through lentiviral vector-mediated protein expression","volume":"25","author":"Lund-Palau","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201733_bib17","doi-asserted-by":"crossref","first-page":"L833","DOI":"10.1152\/ajplung.00173.2001","article-title":"Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia","volume":"282","author":"Southam","year":"2002","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.omta.2026.201733_bib18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1089\/jamp.2012.1007","article-title":"Variability of in vivo fluid dose distribution in mouse airways is visualized by high-speed synchrotron X-ray imaging","volume":"26","author":"Donnelley","year":"2013","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.omta.2026.201733_bib19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s13346-012-0108-9","article-title":"Nasal drug delivery devices: characteristics and performance in a clinical perspective-a review","volume":"3","author":"Djupesland","year":"2013","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.omta.2026.201733_bib20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/0894268041457228","article-title":"Deposition of aerosols in infants and children","volume":"17","author":"Sch\u00fcepp","year":"2004","journal-title":"J. Aerosol Med."},{"key":"10.1016\/j.omta.2026.201733_bib21","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1183\/09031936.93.04060694","article-title":"Particle deposition and resistance in the noses of adults and children","volume":"4","author":"Becquemin","year":"1991","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.omta.2026.201733_bib22","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1007\/s00421-021-04690-9","article-title":"An integrative approach to the pulmonary physiology of exercise: when does biological sex matter?","volume":"121","author":"Archiza","year":"2021","journal-title":"Eur. J. Appl. Physiol."},{"key":"10.1016\/j.omta.2026.201733_bib23","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1152\/japplphysiol.00440.2018","article-title":"Sex differences in large conducting airway anatomy","volume":"125","author":"Dominelli","year":"2018","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.omta.2026.201733_bib24","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF00257443","article-title":"Factors causing dose variability in drug administration","volume":"24","author":"Demicheli","year":"1989","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.omta.2026.201733_bib25","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.0887-378X.2004.00327.x","article-title":"Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages","volume":"82","author":"Kravitz","year":"2004","journal-title":"Milbank Q."},{"key":"10.1016\/j.omta.2026.201733_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106467","article-title":"Dissecting sources of variability in patient response to targeted therapy: anti-HER2 therapies as a case study","volume":"186","author":"Qi","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.omta.2026.201733_bib27","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/thx.2008.108290","article-title":"Granulocyte-macrophage colony-stimulating factor expression in induced sputum and bronchial mucosa in asthma and COPD","volume":"64","author":"Saha","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.omta.2026.201733_bib28","article-title":"Exogenous GM-CSF therapy for autoimmune pulmonary alveolar proteinosis: a systematic literature review","volume":"12","author":"Chen","year":"2025","journal-title":"Front. Med."},{"key":"10.1016\/j.omta.2026.201733_bib29","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1182\/blood-2008-05-155689","article-title":"Granulocyte\/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects","volume":"113","author":"Uchida","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.omta.2026.201733_bib30","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.chom.2022.11.016","article-title":"Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses","volume":"31","author":"Morens","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.omta.2026.201733_bib31","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3390\/vaccines3010148","article-title":"Choice and Design of Adjuvants for Parenteral and Mucosal Vaccines","volume":"3","author":"Savelkoul","year":"2015","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.omta.2026.201733_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2022.852546","article-title":"The Role of IgA in Chronic Upper Airway Disease: Friend or Foe?","volume":"3","author":"S\u00e1nchez Montalvo","year":"2022","journal-title":"Front. Allergy"},{"key":"10.1016\/j.omta.2026.201733_bib33","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/01926230600713475","article-title":"The nose revisited: a brief review of the comparative structure, function, and toxicologic pathology of the nasal epithelium","volume":"34","author":"Harkema","year":"2006","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.omta.2026.201733_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.omta.2025.201655","article-title":"F\/HN-pseudotyped lentiviral vector efficiently transduces non-human primate airways with no evidence of relevant toxicity","volume":"34","author":"Griesenbach","year":"2026","journal-title":"Mol. Ther. Adv."},{"key":"10.1016\/j.omta.2026.201733_bib35","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1016\/j.cell.2022.05.029","article-title":"Designing antibodies as therapeutics","volume":"185","author":"Carter","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.omta.2026.201733_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006299","article-title":"Intranasal antibody gene transfer in mice and ferrets elicits broad protection against pandemic influenza","volume":"5","author":"Limberis","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omta.2026.201733_bib37","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1128\/CVI.00572-14","article-title":"Adeno-associated virus 9-mediated airway expression of antibody protects old and immunodeficient mice against influenza virus","volume":"21","author":"Adam","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.omta.2026.201733_bib38","doi-asserted-by":"crossref","first-page":"e311","DOI":"10.1016\/S1473-3099(22)00311-5","article-title":"Monoclonal antibody therapies against SARS-CoV-2","volume":"22","author":"Focosi","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.omta.2026.201733_bib39","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nbt1399","article-title":"CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression","volume":"26","author":"Hyde","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omta.2026.201733_bib40","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1177\/0192623312438738","article-title":"International harmonization of toxicologic pathology nomenclature: an overview and review of basic principles","volume":"40","author":"Mann","year":"2012","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.omta.2026.201733_bib41","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"}],"container-title":["Molecular Therapy Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26000686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26000686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:44:05Z","timestamp":1788554645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3117387X26000686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S3117387X26000686"],"URL":"https:\/\/doi.org\/10.1016\/j.omta.2026.201733","relation":{},"ISSN":["3117-387X"],"issn-type":[{"value":"3117-387X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using the nose as a factory to secrete proteins into the lungs or circulation","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omta.2026.201733","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201733"}}